Regulatory reform and a strong demand for traditional Chinese medicines (TCM) will help drive Rx-to-OTC switch in China, according to the country’s non-prescription medicines industry association, the CNMA.
“With the improvement of regulations and technical guidelines, it can be anticipated that more and more OTC products will appear in the future,” the CNMA told HBW Insight.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?